Q3 2023

Source filing unavailable

Q3 2023 · —

Revenue

$51.25K

no prior Q3 2022 on file

Net Income

-$324.66K

no prior Q3 2022 on file

EPS Diluted

-$0.00

no prior Q3 2022 on file

Gross Profit$27,132—

Operating Income-$284,866—

Operating Cash Flowderived

Same quarter

Metric	Q3 2023	Q3 2012	Q3 2011
Revenue	$51.25K	$8.57M	$20.78M
Net Income	-$324.66K	-$1.24M	-$1.67M
EPS Diluted	-$0.00	-$0.09	-$0.13

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Cannabis Bioscience International Holdings, Inc. · CIK 1411057 · Engraved from SEC EDGAR